STING1 and diabetic kidney disease: The present study examined how the β-adrenergic receptor agonist isoprenaline (ISO) protected against DKD by regulating the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) signaling pathway through multiple targets.